Survival time of acute lymphoblastic leukemia by chemotherapy can not be generalized depending on the body type, and the five-year survival rate of chemotherapy-sensitive patients is around 90%.
Acute lymphoblastic leukemia is a malignant tumor originating in the hematopoietic system, which can proliferate abnormally in the bone marrow, and may be related to the environment, genes, heredity and other factors, and generally has a better prognosis.
According to relevant statistics, children’s acute lymphoblastic leukemia is relatively sensitive to chemotherapy, and after active treatment, the 5-year survival rate is around 90%. If the patient has no remission from chemotherapy or has a relapse during the treatment period, his/her survival time may be around 6 months.
Acute lymphoblastic leukemia patients need to go to the hospital in time, according to the tumor typing as well as staging, etc. to develop individualized treatment plans, under the guidance of the doctor the correct treatment, can effectively prolong the patient’s survival.